Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptors-Reference-Cited by-同舟云学术

Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptors

Published:2007-08 Issue:8 Volume:28 Page:407-415
ISSN:0165-6147
Container-title:Trends in Pharmacological Sciences
language:en
Short-container-title:Trends in Pharmacological Sciences

Author:

Kenakin Terry

Publisher

Elsevier BV

Subject

Pharmacology,Toxicology

Reference73 articles.

1. New concepts in drug discovery: collateral efficacy and permissive antagonism;Kenakin;Nat. Rev. Drug Discov.,2005

2. A modification of receptor theory. 1956;Stephenson;Br. J. Pharmacol.,1997

3. Agonist–receptor efficacy II: agonist-trafficking of receptor signals;Kenakin;Trends Pharmacol. Sci.,1995

4. Comparative effects of receptor inactivation, 17 β-estradiol and pertussis toxin on dopaminergic inhibition of prolactin secretion in vitro;Meller;J. Pharmacol. Exp. Ther.,1992

5. Differential signal transduction by five splice variants of the PACAP receptor;Spengler;Nature,1993

Cited by 190 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allostery: The Good, the Bad, and the Ugly;Journal of Pharmacology and Experimental Therapeutics;2023-11-02

2. Metadynamics simulations leveraged by statistical analyses and artificial intelligence-based tools to inform the discovery of G protein-coupled receptor ligands;Frontiers in Endocrinology;2022-12-23

3. The optimal design of pharmacological experiments;A Pharmacology Primer;2022

4. Synchronous and Asynchronous Response in Dynamically Perturbed Proteins;The Journal of Physical Chemistry B;2021-01-19

5. New Insights Into Peptide Cannabinoids: Structure, Biosynthesis and Signaling;Frontiers in Pharmacology;2020-12-09